Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.

Abstract

We found that PAX6 gene was specifically methylated in NSCLC, and demonstrated the effect of promoter methylation of PAX6 gene on clinical outcome in NSCLC, indicating the methylated PAX6 may be useful biomarkers for prognostic evaluation in NSCLC.